Article archive / October 1, 2012
Originally published: . Volume 4, No. 2. Source pages: 5.
In a Medscape report on September 14, 2012, reporter Larry Hand writes that an article published in the September Annals of Family Medicine, concludes that “individuals with financial conflicts should be excluded from involvement with medical practice guideline writing, regardless of disclosure, and physicians should be discouraged from meeting with drug company representatives.”
The conclusion was based a study by Linda Hunt, PhD, from the Department of Anthropology, Michigan State. Hunt found the practices of prescribers, pharmaceutical marketing, and clinical consultations were “heavily focused” on prescriptions with little or no discussion of other treatments.
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.